Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced that three Medicare Administrative Contractors (“MACs”) have announced the effective release date of March 15, 2020, for their final Local Coverage Decision […]
Tag: HYPOGLOSSAL NERVE STIMULATION
Inspire Medical Systems Announces Two Draft LCD Determinations Proposing Medicare Coverage
Inspire Medical Systems, Inc., a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced that two draft Local Coverage Determinations (LCDs) were published proposing coverage of Inspire therapy. The proposed draft LCDs are available on the Medicare […]
Inspire Medical Systems Unveils New Brand Identity and Website
Inspire Medical Systems, Inc., developers of the Inspire hypoglossal nerve stimulator, a minimally invasive solution for patients with obstructive sleep apnea (“OSA”), recently revealed its new brand identity and launched a new website. “While our name and focus on patient outcomes remain the same, our brand identity and website, InspireSleep.com, have […]
Colin Huntley MD to Present at 2018 Philadelphia Sleep Conference
Colin Huntley, MD will present a lecture entitled “The Use of Upper Airway Stimulation for the Management of Obstructive Sleep Apnea” at the 2018 Philadelphia Sleep Conference on March 23, 2018. This 60 minute lecture will include a review of the relevant tongue anatomy, discussion […]







